High preoperative serum prealbumin predicts long-term survival in resected esophageal squamous cell cancer
Authors Wei J, Jin M, Shao Y, Ning Z, Huang J
Received 30 April 2019
Accepted for publication 12 August 2019
Published 26 August 2019 Volume 2019:11 Pages 7997—8003
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr Chien-Feng Li
Jun Wei,1 Ming Jin,2 Yingjie Shao,1 Zhonghua Ning,1 Jin Huang1
1Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, People’s Republic of China; 2Department of Clinical Laboratory, The Third Affiliated Hospital of Soochow University, Changzhou 213003, People’s Republic of China
Correspondence: Zhonghua Ning; Jin Huang
Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Road, Changzhou 213003, People’s Republic of China
Tel +86 5 196 887 1132
Purpose: The current study aimed to explore the prognostic role of preoperative prealbumin in resectedesophageal squamous cell carcinoma (ESCC).
Methods: A total of 1374 resected ESCC patients were retrospectively reviewed. Serum for prealbumin analyses was taken within 1–3 days before the operation. Overall survival (OS) was determined using the Kaplan-Meier method; the univariate log-rank test and the multivariate Cox proportional hazard model were used to evaluate the prognostic role of prealbumin. A receiver operating characteristic (ROC) curve was plotted, and the area under the curve (AUC) was calculated to compare the prediction accuracy of prealbumin and albumin for OS.
Results: Finally, 532 patients were included in this study. The 5-year OS rate was favourable for the high prealbumin group versus the median and low prealbumin groups (58.1% vs 44.6% and 31.1%, respectively; P<0.001). Univariate and multivariate analyses identified serum prealbumin, T stage, N stage, differentiation and albumin as independent prognostic factors for OS. ROC curves indicated that prealbumin may be superior to albumin as a prognostic predictor in ESCC patients, but the difference between the two AUCs was not statistically significant (P=0.068).
Conclusion: Prealbumin is an independent prognostic factor and a prognostic indicator of postoperative outcomes in ESCC patients. Future prospective studies are warranted to confirm our results.
Keywords: oesophageal squamous cell carcinoma, prealbumin, albumin, prognosis, serum marker
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]